立方制药
(003020)
| 流通市值：24.74亿 | | | 总市值：34.56亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,900,789,181.92 | 1,524,501,653 | 1,267,790,879.76 | 811,816,818 |
| 营业收入 | 1,900,789,181.92 | 1,524,501,653 | 1,267,790,879.76 | 811,816,818 |
| 二、营业总成本 | 1,682,608,293.1 | 1,357,619,917.08 | 1,134,992,117.8 | 730,374,001.92 |
| 营业成本 | 922,201,876.52 | 815,399,383.49 | 721,723,165.67 | 515,196,866.06 |
| 税金及附加 | 18,335,254.81 | 12,800,392.59 | 9,983,592.17 | 5,661,811.78 |
| 销售费用 | 598,452,170.05 | 426,697,055.82 | 331,810,137.82 | 183,366,298.26 |
| 管理费用 | 61,957,320.43 | 46,562,333.17 | 31,073,547.17 | 15,164,043.13 |
| 研发费用 | 84,955,600.2 | 59,933,416.45 | 42,799,903.69 | 12,539,427.6 |
| 财务费用 | -3,293,928.91 | -3,772,664.44 | -2,398,228.72 | -1,554,444.91 |
| 其中:利息费用 | 1,281,276.05 | 532,670.69 | 1,245,078.23 | 111,613.92 |
| 其中:利息收入 | 4,650,814.35 | 4,386,501.13 | 3,696,303.55 | 1,557,113.87 |
| 加:公允价值变动收益 | 315,515.08 | 2,388,524.44 | 1,380,091.84 | -3,860.64 |
| 加:投资收益 | 27,485,243.74 | 27,502,965.83 | 19,793,055.44 | -365,672.63 |
| 资产处置收益 | - | - | -3,823.43 | -1,358.92 |
| 资产减值损失(新) | -9,201,004.38 | -5,499,770.47 | -3,155,525.52 | -2,412,527.26 |
| 信用减值损失(新) | -2,105,265.78 | -3,851,895.1 | -5,764,914.98 | -1,578,521.58 |
| 其他收益 | 20,594,831.9 | 3,909,811.88 | 1,972,543.64 | 843,372.06 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 255,270,209.38 | 191,331,372.5 | 147,020,188.95 | 77,924,247.11 |
| 加:营业外收入 | 3,145,360.29 | 254,037.33 | 190,688.06 | 111,158.88 |
| 减:营业外支出 | 998,827.95 | 678,004.79 | 561,612.73 | 948.74 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 257,416,741.72 | 190,907,405.04 | 146,649,264.28 | 78,034,457.25 |
| 减:所得税费用 | 23,534,161.97 | 18,076,720.36 | 15,520,014.18 | 11,892,777.23 |
| 六、净利润 | 233,882,579.75 | 172,830,684.68 | 131,129,250.1 | 66,141,680.02 |
| 持续经营净利润 | 233,882,579.75 | 172,830,684.68 | 131,129,250.1 | 66,141,680.02 |
| 归属于母公司股东的净利润 | 226,672,720.79 | 171,375,218.46 | 131,129,250.1 | 66,141,680.02 |
| 少数股东损益 | 7,209,858.96 | 1,455,466.22 | - | - |
| (一)基本每股收益 | 1.42 | 1.09 | 0.82 | 0.54 |
| (二)稀释每股收益 | 1.42 | 1.09 | 0.82 | 0.54 |
| 九、综合收益总额 | 233,882,579.75 | 172,830,684.68 | 131,129,250.1 | 66,141,680.02 |
| 归属于母公司股东的综合收益总额 | 226,672,720.79 | 171,375,218.46 | 131,129,250.1 | 66,141,680.02 |
| 归属于少数股东的综合收益总额 | 7,209,858.96 | 1,455,466.22 | - | - |
| 公告日期 | 2024-04-23 | 2023-10-31 | 2023-08-29 | 2023-04-18 |
| 审计意见(境内) | 标准无保留意见 | | | |